Two human leukocyte antigen (HLA) alleles, DRB1*04.04 and DRB1*03, show a significant correlation with myasthenia gravis (MG) prevalence. Northern Europe exhibits the highest prevalence of MG and ...
The FDA granted accelerated approval to Kresladi for the treatment of pediatric patients with severe LAD-I due to biallelic variants in ITGB2 without an available HLA-matched sibling donor for ...
3d
Rocket Pharmaceuticals Wins FDA Accelerated Approval for KRESLADI Gene Therapy in Severe LAD-I Kids
Rocket Pharmaceuticals (NASDAQ:RCKT) said the U.S. Food and Drug Administration has granted accelerated approval to KRESLADI ...
An MRI-based cohort study shows HLA-B27–positive axial spondyloarthritis is linked to higher inflammation and distinct ...
MedPage Today on MSN
FDA OKs therapy for deadly pediatric immune disorder
Kids with severe LAD-I, caused by ITGB2 mutations, are at risk of life-threatenin ...
The HLA-B27 genetic marker is known to be associated with increased risk for various arthropathies, including JIA. Whether the genetic marker's presence has prognostic value has been uncertain. In ...
Elevated HLA-G levels in HCC patients are linked to worse survival, indicating its potential as a prognostic marker. HCC patients with viral hepatitis or steatotic liver disease show significantly ...
Please provide your email address to receive an email when new articles are posted on . Patients with both psoriasis and hidradenitis suppurativa had the highest overall psoriasis genetic risk score.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results